Literature DB >> 18455706

Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice.

Genshin Mouri1, Eva Jimenez-Mateos, Tobias Engel, Mark Dunleavy, Seiji Hatazaki, Alexia Paucard, Satoshi Matsushima, Waro Taki, David C Henshall.   

Abstract

Mesial temporal lobe epilepsy is the most common, intractable seizure disorder in adults. It is associated with an asymmetric pattern of hippocampal neuron loss within the endfolium (hilus and CA3) and CA1, with limited pathology in extra-hippocampal regions. We previously developed a model of focally-evoked seizure-induced neuronal death using intra-amygdala kainic acid (KA) microinjection and characterized the acute hippocampal pathology. Here, we sought to characterize the full extent of hippocampal and potential extra-hippocampal damage in this model, and the temporal onset of epileptic seizures. Seizure damage assessed at four stereotaxic levels by FluoroJade B staining was most prominent in ipsilateral hippocampal CA3 where it extended from septal to temporal pole. Minor but significant neuronal injury was present in ipsilateral CA1. Extra-hippocampal neuronal damage was generally limited in extent and restricted to the lateral septal nucleus, injected amygdala and select regions of neocortex ipsilateral to the seizure elicitation side. Continuous surface EEG recorded with implanted telemetry units in freely-moving mice detected spontaneous, epileptic seizures by five days post-KA in all mice. Epileptic seizure number averaged 1-4 per day. Hippocampi from epileptic mice 15 days post-KA displayed unilateral CA3 lesions, astrogliosis and increased neuropeptide Y immunoreactivity suggestive of mossy fiber rearrangement. These studies characterize a mouse model of unilateral hippocampal-dominant neuronal damage and short latency epileptogenesis that may be suitable for studying the cell and molecular pathogenesis of human mesial temporal lobe epilepsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455706     DOI: 10.1016/j.brainres.2008.03.061

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  52 in total

1.  RNA aptamer-based functional ligands of the neurotrophin receptor, TrkB.

Authors:  Yang Zhong Huang; Frank J Hernandez; Bin Gu; Katie R Stockdale; Kishore Nanapaneni; Todd E Scheetz; Mark A Behlke; Andrew S Peek; Thomas Bair; Paloma H Giangrande; James O McNamara
Journal:  Mol Pharmacol       Date:  2012-06-29       Impact factor: 4.436

2.  A Peptide Uncoupling BDNF Receptor TrkB from Phospholipase Cγ1 Prevents Epilepsy Induced by Status Epilepticus.

Authors:  Bin Gu; Yang Zhong Huang; Xiao-Ping He; Rasesh B Joshi; Wonjo Jang; James O McNamara
Journal:  Neuron       Date:  2015-10-17       Impact factor: 17.173

3.  TrkB-Shc Signaling Protects against Hippocampal Injury Following Status Epilepticus.

Authors:  Yang Zhong Huang; Xiao-Ping He; Kamesh Krishnamurthy; James O McNamara
Journal:  J Neurosci       Date:  2019-03-29       Impact factor: 6.167

4.  De-repression of myelin-regulating gene expression after status epilepticus in mice lacking the C/EBP homologous protein CHOP.

Authors:  Caroline Sheedy; Claire Mooney; Eva Jimenez-Mateos; Amaya Sanz-Rodriguez; Elena Langa; Catherine Mooney; Tobias Engel
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-12-15

5.  Electroencephalography and behavior patterns during experimental status epilepticus.

Authors:  Ewa Lewczuk; Suchitra Joshi; John Williamson; Mouna Penmetsa; Sarah Shan; Jaideep Kapur
Journal:  Epilepsia       Date:  2017-12-06       Impact factor: 5.864

6.  RNA Polymerase 1 Is Transiently Regulated by Seizures and Plays a Role in a Pharmacological Kindling Model of Epilepsy.

Authors:  Aruna Vashishta; Lukasz P Slomnicki; Maciej Pietrzak; Scott C Smith; Murali Kolikonda; Shivani P Naik; Rosanna Parlato; Michal Hetman
Journal:  Mol Neurobiol       Date:  2018-03-15       Impact factor: 5.590

Review 7.  Targeting BDNF/TrkB pathways for preventing or suppressing epilepsy.

Authors:  Thiri W Lin; Stephen C Harward; Yang Zhong Huang; James O McNamara
Journal:  Neuropharmacology       Date:  2019-08-01       Impact factor: 5.250

8.  Contrasting patterns of Bim induction and neuroprotection in Bim-deficient mice between hippocampus and neocortex after status epilepticus.

Authors:  B M Murphy; T Engel; A Paucard; S Hatazaki; G Mouri; K Tanaka; L P Tuffy; E M Jimenez-Mateos; I Woods; M Dunleavy; H P Bonner; R Meller; R P Simon; A Strasser; J H M Prehn; D C Henshall
Journal:  Cell Death Differ       Date:  2009-09-25       Impact factor: 15.828

9.  Phosphorylation of 14-3-3ζ at serine 58 and neurodegeneration following kainic acid-induced excitotoxicity.

Authors:  Eun Ae Jeong; Byeong Tak Jeon; Jeong Bin Kim; Joon Soo Kim; Yong Woon Cho; Dong Hoon Lee; Hyun Joon Kim; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Gu Seob Roh
Journal:  Anat Cell Biol       Date:  2010-06-30

10.  Experimental neonatal status epilepticus and the development of temporal lobe epilepsy with unilateral hippocampal sclerosis.

Authors:  Mark Dunleavy; Sachiko Shinoda; Clara Schindler; Claire Ewart; Ross Dolan; Oliviero L Gobbo; Christian M Kerskens; David C Henshall
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.